Literature DB >> 12910742

Update on feline calicivirus: new trends.

Kate F Hurley1, Jane E Sykes.   

Abstract

In addition to being important upper respiratory tract pathogens of cats, FCVs are increasingly reported as a cause of a highly contagious febrile hemorrhagic syndrome. Strains causing this syndrome are genetically different from the vaccine strain and other nonhemorrhagic FCV isolates. They apparently differ from one outbreak to another. The syndrome is characterized variably by fever; cutaneous edema and ulcerative dermatitis; upper respiratory tract signs; anorexia; occasionally icterus, vomiting, and diarrhea; and a mortality that approaches 50%. Adult cats tend to be more severely affected than kittens, and vaccination does not appear to have a significant protective effect. Rapid recognition of the disease through identification of clinical signs and appropriate testing, followed by strict institution of disinfection, isolation, and quarantine measures, are essential to prevent widespread mortality resulting from the infection.

Entities:  

Mesh:

Year:  2003        PMID: 12910742     DOI: 10.1016/s0195-5616(03)00025-1

Source DB:  PubMed          Journal:  Vet Clin North Am Small Anim Pract        ISSN: 0195-5616            Impact factor:   2.093


  9 in total

1.  X-ray structure of a native calicivirus: structural insights into antigenic diversity and host specificity.

Authors:  Rong Chen; John D Neill; Mary K Estes; B V Venkataram Prasad
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

2.  Prevalence of feline herpesvirus-1, feline calicivirus, Chlamydia felis, and Bordetella bronchiseptica in a population of shelter cats on Prince Edward Island.

Authors:  Julie Walter; Peter Foley; Carmencita Yason; Raphael Vanderstichel; Anne Muckle
Journal:  Can J Vet Res       Date:  2020-07       Impact factor: 1.310

3.  Antiviral effect of copper chloride on feline calicivirus and synergy with ribavirin in vitro.

Authors:  Dengliang Li; Zhanding Cui; Guohua Li; Liangting Zhang; Ying Zhang; Han Zhao; Shuang Zhang; Yanbing Guo; Yanli Zhao; Fanxing Men; Shihui Zhao; Jiang Shao; Dongju Du; Hailong Huang; Kai Wang; Guixue Hu; Tiansong Li; Yongkun Zhao
Journal:  BMC Vet Res       Date:  2020-07-06       Impact factor: 2.741

4.  Antiviral effect of mefloquine on feline calicivirus in vitro.

Authors:  Phillip McDonagh; Paul A Sheehy; Anne Fawcett; Jacqueline M Norris
Journal:  Vet Microbiol       Date:  2015-02-16       Impact factor: 3.293

Review 5.  Current vaccination strategies in puppies and kittens.

Authors:  Gina M Davis-Wurzler
Journal:  Vet Clin North Am Small Anim Pract       Date:  2006-05       Impact factor: 2.093

6.  Feline calicivirus p32, p39 and p30 proteins localize to the endoplasmic reticulum to initiate replication complex formation.

Authors:  Dalan Bailey; William J Kaiser; Mike Hollinshead; Katy Moffat; Yasmin Chaudhry; Thomas Wileman; Stanislav V Sosnovtsev; Ian G Goodfellow
Journal:  J Gen Virol       Date:  2009-11-11       Impact factor: 3.891

7.  Molecular characterization of feline calicivirus variants from multicat household and public animal shelter in Rio de Janeiro, Brazil.

Authors:  Joylson de Jesus Pereira; Natasha Baumworcel; Júlia Monassa Fioretti; Cinthya Fonseca Domingues; Laís Fernandes de Moraes; Robson Dos Santos Souza Marinho; Maria Clara Rodrigues Vieira; Ana Maria Viana Pinto; Tatiana Xavier de Castro
Journal:  Braz J Microbiol       Date:  2018-02-28       Impact factor: 2.476

Review 8.  2013 update on current vaccination strategies in puppies and kittens.

Authors:  Gina M Davis-Wurzler
Journal:  Vet Clin North Am Small Anim Pract       Date:  2014-03       Impact factor: 2.093

9.  Modified-Live Feline Calicivirus Vaccination Elicits Cellular Immunity against a Current Feline Calicivirus Field Strain in an Experimental Feline Challenge Study.

Authors:  Andrea M Spiri; Marilisa Novacco; Marina L Meli; Martina Stirn; Barbara Riond; Jonathan E Fogle; Felicitas S Boretti; Imogen Herbert; Margaret J Hosie; Regina Hofmann-Lehmann
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.